增生期糖尿病视网膜病变经全视网膜激光治疗的临床观察

doi:10.3969/j.issn.1000-8535.2020.01.013

摘要/Abstract

摘要： 目的探讨增生期糖尿病视网膜病变患者经全视网膜激光光凝治疗的临床效果。方法选取2016年2月—2019年3月我院收治的增生期糖尿病视网膜病变患者97例,使用随机数表法分为观察组(49例)与对照组(48例)。对照组患者接受黄斑格栅样光凝治疗,观察组患者则接受全视网膜激光光凝治疗。收集2组患者手术前后视力、黄斑中心凹容积、乳头周边视网膜神经纤维层厚度及视网膜厚度变化情况等数据进行分析,并对比生活质量评分。结果治疗前,2组患者视乳头旁视网膜神经纤维层厚度、黄斑中心凹容积以及视网膜厚度之间差异无统计学意义(P＞0.05),具有可比性。接受不同治疗后,观察组患者上述3项指标均优于对照组患者(P＜0.05)。观察组患者治疗总有效率为79.59%,高于对照组患者治疗总有效率59.18%(P＜0.05)。此外,观察组患者在精细动作、调节能力、日常生活及远视力、光感和移动4个维度评分均高于对照组患者(P＜0.05)。结论与黄斑格栅样光凝治疗相比,增生期糖尿病视网膜病变患者接受全视网膜激光光凝治疗有助于改善其乳头周边视网膜神经纤维层厚度和黄斑区视网膜厚度,能够显著促进视力恢复,提升患者生活质量,疗效确切。

关键词: 糖尿病, 视网膜病变, 全视网膜激光光凝, 视网膜厚度

Abstract: Objective To investigate the clinical effect of panretinal laser photocoagulation for proliferative diabetic retinopathy. Methods 97 cases of proliferative diabetic retinopathy in our hospital from Feb 2016 to Mar 2019 were enrolled in the study, and were divided into 2 groups randomly. The control group received treatment of macular grid photocoagulation, while the observation group received whole retina laser photocoagulation. Data of visual acuity, macular fovea volume, retinal nerve fiber layer thickness around nipple and retinal thickness before and after operation were collected and analyzed, and quality of life scores were compared. Results Before treatment, there was no significant difference in retinal nerve fiber layer thickness, macular fovea volume and retinal thickness between the two groups (P>0.05), which was comparable. After different treatments, the three indexes mentioned above in the observation group were better than those in the control group (P<0.05). The total effective rate of the observation group was 79.59%, which was higher than that of the control group (59.18%, P<0.05). In addition, the scores of fine motion, accommodation ability, daily life and distant vision, light perception and movement in the observation group were higher than those in the control group (P<0.05). Conclusion Compared with macular grid-like photocoagulation, panretinal laser photocoagulation may improve the retinal nerve fiber layer thickness around the nipple and macular retinal thickness in patients with proliferative diabetic retinopathy. It promotes the recovery of visual acuity, improves the quality of life of patients, and has definite curative effect.

Key words: Diabetes mellitus, Retinopathy, Panretinal laser photocoagulation, Retinal thickness

何伟强. 增生期糖尿病视网膜病变经全视网膜激光治疗的临床观察[J]. 广州医药, 2020, 51(1): 55-58.

HE Weiqiang. Clinical observation of proliferative diabetic retinopathy treated with panretinal laser photocoagulation[J]. Guangzhou Medical Journal, 2020, 51(1): 55-58.

参考文献

[1] SOLOMON S D, CHEW E, DUH E J, et al. Erratum. Diabetic retinopathy: a position statement by the American Diabetes Association.[J]. Diabetes Care, 2017, 40(9):412-418.
[2] CUI J, REN J P, CHEN D N, et al. Prevalence and associated factors of diabetic retinopathy in Beijing, China: a cross-sectional study[J]. Bmj Open, 2017, 7(8):e015473.
[3] GAO X, LI Y, WANG H, et al. Inhibition of HIF-1α decreases expression of pro-inflammatory IL-6 and TNF-α in diabetic retinopathy[J]. Acta Ophthalmologica, 2017, 95(8):45-48.
[4] 中华医学会眼科学会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2014年)[J]. 中华眼科杂志, 2014, 50(11):851-865.
[5] AREVALO J F, LASAVE A F, WU L, et al. intravitreal bevacizumab for proliferative diabetic retinopathy: results from the pan-american collaborative retina study group (pacores) at 24 months of follow-up[J]. Retina, 2017, 37(2):334-343.
[6] MASTROPASQUA R, TOTO L, MASTROPASQUA A, et al. Foveal avascular zone area and parafoveal vessel density measurements in different stages of diabetic retinopathy by optical coherence tomography angiography[J]. Int J Ophthalmol, 2017,10(10):67-73.
[7] CARBONELL M, CASTELBLANCO E, VALLDEPERAS X, et al. Diabetic retinopathy is associated with the presence and burden of subclinical carotid atherosclerosis in type 1 diabetes[J]. Cardiovasc Diabetol, 2018,17(1):66.
[8] TUFAIL A, RUDISILL C, EGAN C, et al. Automated diabetic retinopathy image assessment software: diagnostic accuracy and cost-effectiveness compared with human graders[J]. Ophthalmol, 2017, 124(3):343-351.
[9] MELO L G N, MORALES P H, DRUMMOND K R G, et al. Current epidemiology of diabetic retinopathy in patients with type 1 diabetes: a national multicenter study in Brazil[J]. Bmc Public Health, 2018, 18(1):989.
[10] WANG L Z, CHEUNG C Y, TAPP R J, et al. Availability and variability in guidelines on diabetic retinopathy screening in Asian countries[J]. Br J Ophthalmol, 2017, 101(10):1352.
[11] FUKUDA T, BOUCHI R, TAKEUCHI T, et al. Association of diabetic retinopathy with both sarcopenia and muscle quality in patients with type 2 diabetes: a cross-sectional study[J]. Bmj Open Dia Res Care, 2017, 5(1):e000404.
[12] LEI X, ZENG G, ZHANG Y, et al. Association between homocysteine level and the risk of diabetic retinopathy: a systematic review and meta-analysis[J]. Diabetol Metab Syndr, 2018, 10(1):61.
[13] LIAO P L, LIN C H, LI C H, et al. Anti-inflammatory properties of shikonin contribute to improved early-stage diabetic retinopathy[J]. Sci Rep, 2017 (7):44985.

[1]	许思慧, 甄曼华, 龙小云. 妊娠期糖尿病孕妇应用胰岛素治疗对妊娠结局的影响及安全性分析[J]. 广州医药, 2021, 52(6): 39-42.
[2]	麦高阳, 李鲁强. 绝经前后女性2型糖尿病患者C肽水平与代谢综合征的关系[J]. 广州医药, 2021, 52(6): 76-79.
[3]	许怡文, 李清初. 糖尿病肾病患者肾功能恶化进展的危险因素[J]. 广州医药, 2021, 52(5): 40-43.
[4]	骆超锋, 梁叠锋, 关国宏. 瑞格列奈联合胰岛素治疗2型糖尿病临床疗效及对患者血糖水平的影响[J]. 广州医药, 2021, 52(4): 65-67.
[5]	王曦龄, 李军, 李思源, 高群, 王双. 新疆绝经后女性2型糖尿病LRP5基因rs3736228、rs3781586位点的基因多态性及突变与糖、脂、骨代谢关系的研究[J]. 广州医药, 2021, 52(1): 6-11.
[6]	孟艳辉, 高飞, 吴瑞珊, 宋小燕, 彭红波. 血清25(OH)D₃水平对妊娠期糖尿病的预测价值[J]. 广州医药, 2021, 52(1): 39-42.
[7]	张浩航, 曾建红, 平丽, 李佩兰. 2型糖尿病男性患者血尿酸水平与骨质疏松及临床骨折的相关性研究[J]. 广州医药, 2020, 51(5): 46-49.
[8]	谭静. 基于互联网平台的健康管理模式对2型糖尿病患者血糖管理的效果[J]. 广州医药, 2020, 51(5): 111-114.
[9]	陈劲松, 梁绮华. 妊娠期糖尿病与母婴分娩结局的相关性研究[J]. 广州医药, 2020, 51(2): 110-116.
[10]	朱敏, 阳灿. 基于微信平台对糖尿病患者的健康管理[J]. 广州医药, 2020, 51(1): 92-95.
[11]	黄绍鹏, 黎志锋, 黎玉送. 以家庭为中心的患教模式与传统综合患教模式对糖尿病患者疗效影响的对比分析[J]. 广州医药, 2020, 51(1): 96-99.
[12]	张燕华, 唐奇志, 陈聪, 刘剑文. 利拉鲁肽与二甲双胍对新诊断2型糖尿病患者骨代谢的影响[J]. 广州医药, 2018, 49(5): 48-51.
[13]	刘思容, 荣新洲, 李庆辉. 糖尿病足患者创面病原菌分布及耐药性变迁[J]. 广州医药, 2018, 49(5): 81-85.
[14]	周扬, 陈菲, 马锋, 黄榕. 汉族、维吾尔族老年男性2型糖尿病合并骨质疏松患者25羟维生素D水平分析[J]. 广州医药, 2018, 49(4): 17-19.